NECTAR LIFESCIENCES
Back to Balance Sheet
|
NECTAR LIFESCIENCES Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹-7.48 Cr | ₹-21 Cr | ₹-2.80 Cr | ₹-12 Cr | ₹116 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of NECTAR LIFESCIENCES ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2024 | ₹-7.48 Cr |
Mar2023 | ₹-21 Cr |
Mar2022 | ₹-2.80 Cr |
Mar2021 | ₹-12 Cr |
Mar2020 | ₹116 Cr |
How is Deferred Tax Assets / Liabilities of NECTAR LIFESCIENCES Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹-7.48 Cr | Negative | |
Mar2023 | ₹-21 Cr | Negative | |
Mar2022 | ₹-2.80 Cr | Negative | |
Mar2021 | ₹-12 Cr | Negative | |
Mar2020 | ₹116 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of NECTAR LIFESCIENCES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NECTAR LIFESCIENCES | ₹667.5 Cr | -1% | -24.4% | -33.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹400,617.0 Cr | -2.1% | -9% | 9.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹158,655.0 Cr | 2.4% | 2.2% | 59.7% | Stock Analytics | |
CIPLA | ₹119,511.0 Cr | 1.4% | 2% | 0.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹104,734.0 Cr | -0.9% | -2.8% | 16.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹97,705.1 Cr | -2.1% | -9.2% | -8.7% | Stock Analytics |
NECTAR LIFESCIENCES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NECTAR LIFESCIENCES | -1% |
-24.4% |
-33.9% |
SENSEX | -0.4% |
-1.4% |
5.4% |
You may also like the below Video Courses